Abstract
This study was conducted to investigate the relationship between the carbon chain length/double bonds of alkyl esters and their inhibitory potency/mechanism on carboxylesterases (CESs). CESs activity was evaluated by inhibition of adefovir dipivoxil (ADV) metabolism in rat intestinal homogenates. Furthermore, the inhibitory effect of BNPP and ethyl (E)-hex-2-enoate (C8:1) on drug absorption was evaluated in situ intestinal perfusion model. The results showed that the rank order of the inhibitory potency on CESs was C10:0 > C8:0 > C6:0 > C4:0 > C12:0, C8:1 > C8:0, C6:1 > C6:0, while the esters (C14:0, C13:1, C16:0, C18:0, C17:1, C20:0) were found to have no inhibitory effect at investigated concentrations. However, the unsaturated esters (C20:1, C20:2, C20:3) displayed the inhibitory effect on CESs. Moreover, the double reciprocal plots indicated that alky esters inhibited the CESs in competitive and mixed competitive ways which were reversible. In addition, the result of most effective CESs inhibitor C8:1 from in situ experiment showed that C8:1 can inhibit the CESs-mediated intestinal metabolism and improve the drug absorption. And the inhibition had no time-dependent effect, compared with that of BNPP groups. The study suggested that alkyl esters can be served as effective and reversible CESs inhibitors, besides that their inhibitory potency/mechanism can be affected by their carbon chain length/double bonds.
Similar content being viewed by others
Abbreviations
- ADF:
-
Adefovir
- ADV:
-
Adefovir dipivoxil
- BNPP:
-
Bis-p-nitrophenylphosphate
- CESs:
-
Carboxylesterases
- EE:
-
Ethyl (E)-hex-2-enoate
- LDH:
-
Lactate dehydrogenase
- Mono-ADV:
-
Mono-(POM) PMEA
References
Bianca ML, Ronald TB (2006) Enzymes involved in the bioconversion of ester-based prodrugs. J Pharm Sci 95:1177–1195
Heikinheimo P, Goldman A, Jeffries C, Ollis D (1999) Of barn owls and bankers: a lush variety of alpha/beta hydrolases. Struct Fold Des 7:R141–R146
Tetsuo S, Masakiyo H (1998) The mammalian carboxylesterase: from molecules to functions. Annu Rev Pharmacol Toxicol 38:257–288
Hyatt JL, Tsurkan L, Wierdl M, Edwards CC, Danks MK, Potter PM (2006) Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity. Mol Cancer Ther 5(9):2281–2288
Naesens L (1999) Inhibition of intestinal metabolism of the antiviral ester prodrug Bis(POC)-PMPA by nature identical fruit extracts as a strategy to enhance its oral absorption: in vitro study. Pharm Res 16(7):1035–1040
Van Gelder J, Deferme S, Naesens L, De Clercq E, van den Mooter G, Kinget R, Augustijns P (2002) Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures. Drug Metab Dispos 30(8):924–930
Zhang J, Burnell JC, Dumaual N, Bosron WF (1999) Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1. J Pharmacol Exp Ther 290:314–318
Wheelock CE, Shan G, Ottea J (2005) Overview of carboxylesterases and their role in the metabolism of insecticides. J Pestic Sci 30:75–83
Redinbo MR, Potter PM (2005) Mammalian carboxylesterases: from drug targets to protein therapeutics. Drug Discov Today 10:313–325
Brandt E, Heymann E, Mentlein R (1980) Selective inhibition of rat liver carboxylesterases by various organophosphorus diesters in vivo and in vitro. Biochem Pharmacol 29:1927–1931
Harada T, Nakagawa Y, Wadkins RM, Potter PM, Wheelock CE (2009) Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure–activity relationship analysis. Bioorg Med Chem 17:149–164
Hyatt JL, Moak T, Hatfield MJ, Tsurkan L, Edwards CC, Wierdl M, Danks MK, Wadkins RM, Potter PM (2007) Selective inhibition of carboxylesterases by isatins, indole-2, 3-diones. J Med Chem 50:1876–1885
Van Gelder J, Deferme S, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P (2000) Increased absorption of the antiviral ester prodrug tenofovir disoproxil in rat ileum by inhibiting its intestinal metabolism. Drug Metab Dispos 28:1394–1396
Ping L, Patrick SC, Liang-Shang G, Suresh KB (2007) Esterase inhibition attribute of grapefruit juice leading to a new drug interaction. Drug Metab Dispos 35:1023–1031
Ping L, Patrick SC, Liang-Shang G, Suresh KB (2007) Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction. Drug Metab Dispos 35:1203–1208
Van Gelder J, Shafiee M, De Clercq E, Penninckx F, Van den Mooter G, Kinget R, Augustijns P (2000) Species-dependent and site-specific intestinal metabolism of ester prodrugs. Int J Pharm 205:93–100
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Xiuhua R, Xinliang M, Lei C, Kewen X, Luqin S, Jun Q, Aaron DS, Gao L (2009) Nonionic surfactants are strong inhibitors of cytochrome P4503A biotransformation activity in vitro and in vivo. Eur J Pharm Sci 36:401–411
Kelsey JA, Bayles KW, Shafii B, McGuire MA (2006) Fatty acids and monoacylglycerols inhibit growth of Staphylococcus aureus. Lipids 41:951–961
Du ZY, Demizieux L, Degrace P, Gresti J, Mointrot B, Liu YJ, Tian LX, Cao JM, Clouet P (2004) Alteration of 20:5n-3 and 22:6n-3 fat contents and liver peroxisomal activities in fenofibrate-treated rainbow trout. Lipids 39:849–855
Molina AJ, Prieto JG, Merino G, Mendoza G, Real R, Pulido MM, Alvarez AI (2007) Effects of ischemia–reperfusion on the absorption and esterase metabolism of diltiazem in rat intestine. Life Sci 80:397–407
Annaert P, Tukker JT, Van Gelder J, Naesens L, De Clercq E, Van den Mooter G, Kinget R, Augustijns P (2000) In vitro, ex vivo and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil. J Pharm Sci 89:1054–1062
Annaert P, Kinget R, Naesens L, De Clercq E, Augustijns P (1997) Transport, uptake, and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an in vitro cell culture system of the intestinal mucosa (Caco-2). Pharm Res 14:492–496
Li yan Z, Xiao yan C, Yong Z, Han yu Y, Da fang Z (2003) Determination of adefovir in monkey plasma by liquid chromatography-tandem mass spectrometry. Acta Pharm Sin 38:120–123
Tseng SJ, Hsu JP (1990) A comparison of the parameter estimating procedures for the Michaelis–Menten model. J Theor Biol 145(4):457–464
Michael L (1999) Fatty acid ethyl esters: nonoxidative ethanol metabolites with emerging biological and clinical significance. Lipids 34:281–285
Porter CJH, Pouton CW (2008) Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Delivery Rev 60:625–637
Durrer A, Wernly-Chung GN, Boss G, Testa B (1992) Enzymic hydrolysis of nicotinate esters: comparison between plasma and liver catalysis. Xenobiotica 22:273–282
Foroutan SM, Watson DG (1999) The in vitro evaluation of polyethylene glycol esters of hydrocortisone 21-succinate as ocular prodrugs. Int J Pharm (Amst) 182:79–92
Teruko I, Megumi T, Mayumi S, Masakiyo H, Kan C (2006) Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine. Drug Metab Dispos 34:1734–1741
Fleming CD, Bencharit S, Edwards CC, Hyatt JL, Tsurkan L, Bai F, Fraga C, Morton CL, Howard-Williams EL, Potter PM, Redinbo MR (2005) Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil. J Mol Biol 352:165–177
Gibson GG, Cinti DL, Sligar SG, Schenkman JB (1980) The effect of microsomal fatty acids and other lipids on the spin state of partially purified cytochrome P-450. J Biol Chem 255(5):1867–1873
Berg J, Tymoczko JL, Stryer L (2002) Biochemistry. W.H. Freeman & Co., New York
White KN, Eggermont J, Hope DB (1987) Effect of the carboxylesterase inhibitor bis-(4-nitrophenyl)phosphate in vivo on aspirin hydrolase and carboxylesterase activities at first-pass sites of metabolism in the guinea pig. Biochem Pharmacol 36:2687–2688
Mentlein R, Rix-Matzen H, Heymann E (1988) Subcellular localization of non-specific carboxylesterases, acylcarnitine hydrolase, monoacylglycerol lipase and palmitoyl-CoA hydrolase in rat liver. Biochim Biophys Acta 964:319–328
Masaki K, Hashimoto M, Imai T (2007) Intestinal first-pass metabolism via carboxylesterase in rat jejunum and ileum. Drug Metab Dispos 35:1089–1095
Krisch K (1971) Carboxylic ester hydrolases. In: Boyer PD (ed) The enzymes. Academic Press, New York
Wu SJ, Robinson JR (1999) Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone. Pharm Res 16:1266–1272
Acknowledgments
We thank Mrs Dan Li for help on calculating K i/K i′ values by offering the GraphPad Prism 4.00 (GraphPad Software, San Diego California, USA). This work was supported by the National Natural Sciences Foundation of China (No. 30701054) and National Science & Technology Major Project “Key New Drug Creation and Manufacturing Program” (No. 2009ZX09301-001). This work was also supported in part by the National Basic Research Program of China (No. 2009CB930300).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Li, P., Zhu, Cl., Zhang, Xx. et al. Reversible Inhibitory Effects of Saturated and Unsaturated Alkyl Esters on the Carboxylesterases Activity in Rat Intestine. Lipids 45, 603–612 (2010). https://doi.org/10.1007/s11745-010-3434-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-010-3434-z